Tagged atopic-dermatitis

Eczema Research Breakthrough: Specific Bacteria and Metabolites Targeted for Advanced Treatments
Press Release

Eczema Research Breakthrough: Specific Bacteria and Metabolites Targeted for Advanced Treatments

 Insights into the Skin Microbiome-Metabolome Nexus Revolutionize Eczema Management Strategies Read More
Press Release

The Assistance Fund Opens New Program for Atopic Dermatitis

 Financial Assistance From The Assistance Fund Now Available for Eligible People Living With Atopic Dermatitis Read More
Symposium to Highlight Advances in Skin Barrier Research
Press Release

Symposium to Highlight Advances in Skin Barrier Research

 Event focuses on science of skin barrier damage and repair in pediatric patients with atopic dermatitis, or “eczema” Read More
The Foundation for Dermatology Education to Host the 3rd Annual Live Revolutionizing Atopic Dermatitis (RAD) Conference - Saturday, December 11 - Monday, December 13, 2021
Press Release

The Foundation for Dermatology Education to Host the 3rd Annual Live Revolutionizing Atopic Dermatitis (RAD) Conference - Saturday, December 11 - Monday, December 13, 2021

 Registration now open to the only global multidisciplinary conference featuring world-class speakers, cutting-edge research presentations, case study reviews and more specifically in the field of Atopic Dermatitis Read More
The Foundation for Dermatology Education to Host the Fourth Annual Revolutionizing Atopic Dermatitis (RAD) Virtual Conference - Sunday, June 13, 2021
Press Release

The Foundation for Dermatology Education to Host the Fourth Annual Revolutionizing Atopic Dermatitis (RAD) Virtual Conference - Sunday, June 13, 2021

 Cutting-edge research presentations, expert panelists, and attendee Q&As make this a must-attend event for anyone involved in the field of Atopic Dermatitis Read More
Analysis of Over 1,000 Atopic Dermatitis Patients Highlights Moderate-to-Severe Patient Candidacy for Biologics and Small Molecules and Real-World Treatment Patterns for Patients Treated With Sanofi/Regeneron's Dupixent
Press Release

Analysis of Over 1,000 Atopic Dermatitis Patients Highlights Moderate-to-Severe Patient Candidacy for Biologics and Small Molecules and Real-World Treatment Patterns for Patients Treated With Sanofi/Regeneron's Dupixent

 Candidacy analysis for pipeline agents reveals that JAK inhibitors, such as Pfizer's PF-0496582, AbbVie's upadacitinib and Incyte's topical ruxolitinib have the most potential upside if approved Read More
AllergyStore.com Launches Skinnies Seamless Skinwear in North America
Press Release

AllergyStore.com Launches Skinnies Seamless Skinwear in North America

 Providing needed relief for Eczema sufferers Read More